Browne Eva, Lawrentschuk Nathan, Jack Greg S, Davis Niall F
Royal College of Surgeons, Dublin, Ireland.
Department of Urology, The Austin Hospital, Victoria, Australia.
Can Urol Assoc J. 2021 Jan;15(1):E48-E57. doi: 10.5489/cuaj.6466.
We aimed to perform a systematic review and meta-analysis on the long-term durability, incidence of complications, and patient satisfaction outcomes in ileal conduit (IC) and orthotopic neobladder (ONB).
A systematic electronic literature search was performed in Medline, Embase, Cochrane Library, and Scopus using MeSH and free-text search terms "Urinary diversion" AND "Ileal conduit" AND "Neobladder." The search concluded June 19, 2018. Inclusion criteria were those patients who had a cystectomy and required urinary diversion by either IC or neobladder.
In total, 32 publications met the inclusion criteria. Data were available on 46 787 patients (n=36 719 for IC and n=10 068 for ONB). Meta-analyses showed that IC urinary diversions performed less favorably than ONB in terms of re-operation rates, Clavien-Dindo complications, and mortality rates; odds ratios (ORs) and 95% confidence intervals (CIs) were 1.76 (1.24, 2.50), p<0.01; 1.16 (1.09, 1.22), p<0.01; and 6.29 (5.30, 7.48), p<0.01, respectively. IC urinary diversion performed better than ONB in relation to urinary tract infection rates and ureteric stricture rates, OR and 95% CI 0.67 (0.58, 0.77), p<0.01; and 0.70 (0.55, 0.89), p<0.01, respectively.
Our results show that there is no significantly increased morbidity with ONB compared to IC. Selection of either urinary diversion technique should be based on factors such as tumor stage, comorbidities, surgical experience, and patient acceptance of postoperative sequalae.
我们旨在对回肠膀胱术(IC)和原位新膀胱术(ONB)的长期耐用性、并发症发生率及患者满意度结果进行系统评价和荟萃分析。
在Medline、Embase、Cochrane图书馆和Scopus数据库中进行系统的电子文献检索,使用医学主题词(MeSH)和自由文本检索词“尿流改道”、“回肠膀胱术”和“新膀胱术”。检索截至2018年6月19日。纳入标准为接受膀胱切除术并需要通过IC或新膀胱术进行尿流改道的患者。
共有32篇出版物符合纳入标准。获取了46787例患者的数据(IC组36719例,ONB组10068例)。荟萃分析显示,在再次手术率、Clavien-Dindo并发症和死亡率方面,IC尿流改道的效果不如ONB;优势比(OR)和95%置信区间(CI)分别为1.76(1.24,2.50),p<0.01;1.16(1.09,1.22),p<0.01;以及6.29(5.30,7.48),p<0.01。在尿路感染率和输尿管狭窄率方面,IC尿流改道的表现优于ONB,OR和95%CI分别为0.67(0.58,0.77),p<0.01;以及0.70(0.55,0.89),p<0.01。
我们的结果表明,与IC相比,ONB并没有显著增加发病率。选择任何一种尿流改道技术都应基于肿瘤分期、合并症、手术经验以及患者对术后后遗症的接受程度等因素。